Related Experiment Videos
Psychopharmacology in the medically ill. General principles
1Institute of Psychiatry, Medical University of South Carolina, Charleston.
Advances in Psychosomatic Medicine
|January 1, 1994
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Irritable bowel syndrome, anxiety, and depression: what are the links?
The Journal of clinical psychiatry·2002
Insight and treatment outcome in obsessive-compulsive disorder.
Comprehensive psychiatry·2001
Citalopram treatment of fluoxetine nonresponders.
The Journal of clinical psychiatry·2001
Noradrenergic function and clinical outcome in antidepressant pharmacotherapy.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2001
Joint hypermobility, anxiety and psychosomatics: two and a half decades of progress toward a new phenotype.
Advances in psychosomatic medicine·2015
Huntington's disease: looking beyond the movement disorder.
Advances in psychosomatic medicine·2015
Psychodermatology.
Advances in psychosomatic medicine·2015
Coping with losses, grief, and mourning in prostate cancer.
Advances in psychosomatic medicine·2015
Telomeres, early-life stress and mental illness.
Advances in psychosomatic medicine·2015
Fibromyalgia and chronic fatigue syndrome: management issues.
Advances in psychosomatic medicine·2015
Membrane Phase Separation: An Emerging Biophysical Perspective on Food-Derived Bioactive Peptides.
Journal of agricultural and food chemistry·2026
Neuropharmacological and behavioral characterization of 3F-phenetrazine, a novel amphetamine-like substance, in male mice and rats.
European journal of pharmacology·2026
A practical approach to estimate the potency of an antagonist in a functional experiment with isolated preparations of rat aorta.
Advances in physiology education·2026
Species Divergence in Oxytocin-Dependent Yawning on a Conserved Glutamatergic Erection Circuit.
Neuroscience bulletin·2026
The Combination of Buprenorphine and Pregabalin in the Management of Peripheral Neuropathic Pain: A Phase IV, Randomized, Double-Blind and Placebo-Controlled Clinical Trial.
European journal of pain (London, England)·2026